Topic · Silymarin and Mushroom Poisoning
Most cited papers in Silymarin and Mushroom Poisoning
What are the most cited papers in Silymarin and Mushroom Poisoning?
The most cited paper in Silymarin and Mushroom Poisoning is "ACETYLORNITHINASE OF ESCHERICHIA COLI: PARTIAL PURIFICATION AND SOME PROPERTIES" (Henry J. Vogel, David M. Bonner, 1956), with 4,027 citations. Next come "Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial" (3,732) and "Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers" (2,136).
Showing 50 of 100 papers. Every paper with more than 286 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | ACETYLORNITHINASE OF ESCHERICHIA COLI: PARTIAL PURIFICATION AND SOME PROPERTIES Henry J. Vogel, David M. Bonner · Journal of Biological Chemistry | 1956 | 4,027 |
| 2 | Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial Jordi Bruix et al. · The Lancet | 5 Dec 2016 | 3,732 |
| 3 | Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers Scott Michael Lippman et al. · JAMA | 9 Dec 2008 | 2,136 |
| 4 | What is the True Solubility Advantage for Amorphous Pharmaceuticals? Bruno C. Hancock, Michael Parks · Pharmaceutical Research | Apr 2000 | 1,352 |
| 5 | Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers Ricardo Tomas Spielberger, Patrick J. Stiff, William Bensinger et al. · New England Journal of Medicine | 15 Dec 2004 | 902 |
| 6 | Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression Gary L. Davis, Miriam J. Alter, Hashem B. El‐Serag et al. · Gastroenterology | 26 Oct 2009 | 883 |
| 7 | Fluorescent phallotoxin, a tool for the visualization of cellular actin. Elisabeth Wulf, Axel Deboben, Friedlinde A. Bautz et al. · Proceedings of the National Academy of Sciences | Sep 1979 | 808 |
| 8 | Treatment of Acute Hepatitis C with Interferon Alfa-2b Elmar Jaeckel, Markus Cornberg, Heiner H. Wedemeyer et al. · New England Journal of Medicine | 15 Nov 2001 | 805 |
| 9 | Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Sandro Marcelo Rossi, Michele Stasi, Elisabetta Buscarini et al. · American Journal of Roentgenology | Sep 1996 | 762 |
| 10 | Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. L C Clark, G F Combs, B W Turnbull et al. · PubMed | 25 Dec 1996 | 758 |
| 11 | Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data Riccardo Antonio Lencioni, Thierry de Baère, Michael C. Soulen et al. · Hepatology | 14 Jan 2016 | 746 |
| 12 | Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives Peter Surai · Antioxidants | 20 Mar 2015 | 736 |
| 13 | The Use of Silymarin in the Treatment of Liver Diseases Reinhard Saller, Remy F. Meier, Reto Brignoli · Drugs | 2001 | 724 |
| 14 | Milk Thistle ( Silybum marianum ) for the Therapy of Liver Disease Kenneth D. Flora, Martin Hahn, Hugo R. Rosen et al. · The American Journal of Gastroenterology | Feb 1998 | 723 |
| 15 | Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods Tamás Baranyai, Kata Herczeg, Zsófia Onódi et al. · PLoS ONE | 21 Dec 2015 | 697 |
| 16 | Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro Ying Zhou, Huitao Xu, Wenrong Xu et al. · Stem Cell Research & Therapy | 25 Apr 2013 | 675 |
| 17 | Decreased incidence of prostate cancer with selenium supplementation: results of a double‐blind cancer prevention trial Clark, Clark, Dalkin et al. · British Journal of Urology | May 1998 | 675 |
| 18 | Resveratrol as an anti-cancer agent: A review Abdur Rauf, Muhammad Imran, Masood Sadiq Butt et al. · Critical Reviews in Food Science and Nutrition | 21 Dec 2016 | 666 |
| 19 | Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial Calin Ioan Cainap, Shukui Qin, Wen‐Tsung Huang et al. · Journal of Clinical Oncology | 9 Dec 2014 | 639 |
| 20 | A review on exosomes application in clinical trials: perspective, questions, and challenges Jafar Rezaie, Maryam Feghhi, Tahereh Etemadi · Cell Communication and Signaling | 19 Sep 2022 | 614 |
| 21 | Milk thistle in liver diseases: past, present, future Ludovico Abenavoli, Raffaele Capasso, Nataša Milić et al. · Phytotherapy Research | 7 Jun 2010 | 600 |
| 22 | Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids Berrın Özçelık, Murat Kartal, İlkay Erdoğan Orhan · Pharmaceutical Biology | 11 Mar 2011 | 588 |
| 23 | SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma Andrew Xiuxuan Zhu, Olivier Rosmorduc, Thomas R. Jeffry Evans et al. · Journal of Clinical Oncology | 30 Dec 2014 | 584 |
| 24 | Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects Shaiju K. Vareed, Madhuri Kakarala, Mack T. Ruffin et al. · Cancer Epidemiology Biomarkers & Prevention | Jun 2008 | 582 |
| 25 | Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma Masatoshi Kudo et al. · European Journal of Cancer | 21 Jun 2011 | 578 |
| 26 | Silybin and Silymarin - New and Emerging Applications in Medicine Radek Gažák, Daniela Walterová, Vladimı́r Křen · Current Medicinal Chemistry | Feb 2007 | 576 |
| 27 | Milk-derived exosomes for oral delivery of paclitaxel Ashish Kumar Agrawal, Farrukh Aqil, Jeyaprakash Jeyabalan et al. · Nanomedicine Nanotechnology Biology and Medicine | 11 Mar 2017 | 547 |
| 28 | Tissue invasion and metastasis: Molecular, biological and clinical perspectives Wen G. Jiang et al. · Seminars in Cancer Biology | 11 Apr 2015 | 532 |
| 29 | Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Suresh Chandra Pradhan, Chandrashekaran Girish · PubMed | Nov 2006 | 518 |
| 30 | Fisetin: A Dietary Antioxidant for Health Promotion Naghma Khan, Deeba N. Syed, Nihal Ahmad et al. · Antioxidants and Redox Signaling | 2 Nov 2012 | 516 |
| 31 | Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial Anna J. Duffield‐Lillico, B.L. Dalkin, Marvin Ellsworth Reid et al. · British Journal of Urology | 16 Apr 2003 | 516 |
| 32 | Potassium transport in fungi and plants Alonso Rodríguez‐Navarro · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes | Mar 2000 | 510 |
| 33 | α-Amanitin: A specific inhibitor of one of two DNA-dependent RNA polymerase activities from calf thymus C. Kédinger, Marek Gniazdowski, Jean‐Louis Mandel et al. · Biochemical and Biophysical Research Communications | 1970 | 499 |
| 34 | Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver Peter Ferenci, B Dragosics, H. Dittrich et al. · Journal of Hepatology | Jul 1989 | 499 |
| 35 | A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel Rosemary C. Polomano, Andrew J. Mannes, Uraina S. Clark et al. · Pain | Dec 2001 | 498 |
| 36 | Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review Anton Gillessen, Hartmut Hans-Jürgen Schmidt · Advances in Therapy | 17 Feb 2020 | 497 |
| 37 | Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years Alessandro Federico, Marcello Dallio, C. Loguercio · Molecules | 24 Jan 2017 | 491 |
| 38 | Amatoxins, Phallotoxins, Phallolysin, and Antamanide: The Biologically Active Components of Poisonous Amanita Mushroom Theodor Wieland, Heinz Faulstich, LUIGI FIUME · Critical Reviews in Biochemistry and Molecular Biology | 1978 | 478 |
| 39 | Milk thistle ( Silybum marianum ): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases Ludovico Abenavoli, Angelo Antonio Izzo, Nataša Milić et al. · Phytotherapy Research | 6 Aug 2018 | 475 |
| 40 | Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial Michel Belehradek, Christian Domenge, Bernard Luboinski et al. · Cancer | 15 Dec 1993 | 456 |
| 41 | Silybin and silymarin - new effects and applications Vladimír Křen, Daniela Walterová · Biomedical Papers | Jul 2005 | 448 |
| 42 | Hepatoprotective effect of silymarin Nancy Vargas-Mendoza · World Journal of Hepatology | 2014 | 444 |
| 43 | Multitargeted therapy of cancer by silymarin Kumaraguruparan Ramasamy, Rajesh Agarwal · Cancer Letters | 10 May 2008 | 442 |
| 44 | Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anindita Mukerjee, Jamboor K. Vishwanatha · PubMed | Oct 2009 | 441 |
| 45 | Medicinal mushroom modulators of molecular targets as cancer therapeutics Ben-Zion Zaidman, Majed Yassin, Jamal A. Mahajna et al. · Applied Microbiology and Biotechnology | 22 Feb 2005 | 440 |
| 46 | Treatment of Hepatitis C Anita A. Kohli, Ashton A. Shaffer, Amy C Sherman et al. · JAMA | 12 Aug 2014 | 439 |
| 47 | Acute Selenium Toxicity Associated With a Dietary Supplement Jennifer MacFarquhar · Archives of Internal Medicine | 8 Feb 2010 | 426 |
| 48 | Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR analysis and docking studies Maria José Alves, Isabel C.F.R. Ferreira, Hugo J.C. Froufe et al. · Journal of Applied Microbiology | 19 Mar 2013 | 423 |
| 49 | Treatment of Amatoxin Poisoning: 20-Year Retrospective Analysis Françoise Enjalbert, Sylvie Rapior, Janine Nouguier-Soulé et al. · Journal of Toxicology Clinical Toxicology | 2002 | 423 |
| 50 | Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network Victor J. Navarro, Huiman Xie Barnhart, Herbert L. Bonkovsky et al. · Hepatology | 15 Jul 2014 | 419 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.